402 related articles for article (PubMed ID: 22438791)
1. Post-translational modifications of nuclear receptors and human disease.
Anbalagan M; Huderson B; Murphy L; Rowan BG
Nucl Recept Signal; 2012; 10():e001. PubMed ID: 22438791
[TBL] [Abstract][Full Text] [Related]
2. Acetylation of nuclear receptors in health and disease: an update.
Ashton AW; Dhanjal HK; Rossner B; Mahmood H; Patel VI; Nadim M; Lota M; Shahid F; Li Z; Joyce D; Pajkos M; Dosztányi Z; Jiao X; Pestell RG
FEBS J; 2024 Jan; 291(2):217-236. PubMed ID: 36471658
[TBL] [Abstract][Full Text] [Related]
3. The functional significance of nuclear receptor acetylation.
Popov VM; Wang C; Shirley LA; Rosenberg A; Li S; Nevalainen M; Fu M; Pestell RG
Steroids; 2007 Feb; 72(2):221-30. PubMed ID: 17291555
[TBL] [Abstract][Full Text] [Related]
4. Posttranslational modification of the androgen receptor in prostate cancer.
van der Steen T; Tindall DJ; Huang H
Int J Mol Sci; 2013 Jul; 14(7):14833-59. PubMed ID: 23863692
[TBL] [Abstract][Full Text] [Related]
5. Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications.
Lumahan LEV; Arif M; Whitener AE; Yi P
Cells; 2024 Jan; 13(2):. PubMed ID: 38275816
[TBL] [Abstract][Full Text] [Related]
6. [Post-translational modifications modulate estrogen receptor alpha activity in breast tumors].
Poulard C; Bouchekioua-Bouzaghou K; Sentis S; Corbo L; Le Romancer M
Med Sci (Paris); 2010; 26(6-7):636-40. PubMed ID: 20619167
[TBL] [Abstract][Full Text] [Related]
7. Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARγ.
Floyd ZE; Stephens JM
Biochim Biophys Acta; 2012 Jul; 1822(7):1090-5. PubMed ID: 22504298
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-like protein modifications in prostate and breast cancer.
Wu F; Mo YY
Front Biosci; 2007 Jan; 12():700-11. PubMed ID: 17127330
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the androgen receptor by post-translational modifications.
Coffey K; Robson CN
J Endocrinol; 2012 Nov; 215(2):221-37. PubMed ID: 22872761
[TBL] [Abstract][Full Text] [Related]
10. Post-translational modification of the androgen receptor.
Gioeli D; Paschal BM
Mol Cell Endocrinol; 2012 Apr; 352(1-2):70-8. PubMed ID: 21820033
[TBL] [Abstract][Full Text] [Related]
11. Post-translational modifications of steroid receptors.
Faus H; Haendler B
Biomed Pharmacother; 2006 Nov; 60(9):520-8. PubMed ID: 16949786
[TBL] [Abstract][Full Text] [Related]
12. The Potential Roles of Post-Translational Modifications of PPARγ in Treating Diabetes.
Ji X; Zhang W; Yin L; Shi Z; Luan J; Chen L; Liu L
Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551260
[TBL] [Abstract][Full Text] [Related]
13. Functional Regulation of PPARs through Post-Translational Modifications.
Brunmeir R; Xu F
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895749
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.
Bonofiglio D; Gabriele S; Aquila S; Catalano S; Gentile M; Middea E; Giordano F; Andò S
Clin Cancer Res; 2005 Sep; 11(17):6139-47. PubMed ID: 16144913
[TBL] [Abstract][Full Text] [Related]
15. Acetylation of nuclear receptors in cellular growth and apoptosis.
Fu M; Wang C; Zhang X; Pestell RG
Biochem Pharmacol; 2004 Sep; 68(6):1199-208. PubMed ID: 15313417
[TBL] [Abstract][Full Text] [Related]
16. The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity.
Fu M; Rao M; Wu K; Wang C; Zhang X; Hessien M; Yeung YG; Gioeli D; Weber MJ; Pestell RG
J Biol Chem; 2004 Jul; 279(28):29436-49. PubMed ID: 15123687
[TBL] [Abstract][Full Text] [Related]
17. Targeting the glucocorticoid receptor in breast and prostate cancers.
Kach J; Conzen SD; Szmulewitz RZ
Sci Transl Med; 2015 Sep; 7(305):305ps19. PubMed ID: 26378243
[TBL] [Abstract][Full Text] [Related]
18. SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells.
Kaikkonen S; Jääskeläinen T; Karvonen U; Rytinki MM; Makkonen H; Gioeli D; Paschal BM; Palvimo JJ
Mol Endocrinol; 2009 Mar; 23(3):292-307. PubMed ID: 19116244
[TBL] [Abstract][Full Text] [Related]
19. Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer.
Leehy KA; Regan Anderson TM; Daniel AR; Lange CA; Ostrander JH
J Mol Endocrinol; 2016 Apr; 56(3):R99-R114. PubMed ID: 26831511
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer.
Ciupek A; Rechoum Y; Gu G; Gelsomino L; Beyer AR; Brusco L; Covington KR; Tsimelzon A; Fuqua SA
Breast Cancer Res Treat; 2015 Nov; 154(2):225-37. PubMed ID: 26487496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
